YC

Yiheng Capital

North America, California, United States, San Francisco

Description

Yiheng Capital is an alternative asset management company that focuses on specific economic sectors and undervalued enterprises.

Investor Profile

Yiheng Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (67%)
  • Post Ipo Equity (33%)

Country Focus

  • France (33%)
  • China (33%)
  • United States (33%)

Industry Focus

  • Medical Device
  • 3d Printing
  • Biopharma
  • Biotechnology
  • Clinical Trials
  • Medical
  • Dental
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yiheng Capital frequently co-invest with?

Qatar Holding
Asia, Al Aqabah, Jordan, Qatar
Co-Investments: 1
ZWC Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
Marathon Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Yiheng Capital?

Inventiva Pharma

Daix, Bourgogne, France

Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

BiopharmaBiotechnologyClinical TrialsMedicalMedical Device
Post Ipo EquityAug 31, 2023
Amount Raised: $38,709,132
SprintRay

Los Angeles, California, United States

SprintRay is a 3D printer manufacturer that focuses on digital dentistry.

3D PrintingDentalHealth CareMedical Device
Series DOct 10, 2022
Amount Raised: $100,000,000
Xunshi Technology

Hangzhou, Zhejiang, China

Xunshi Technology is a professional engaged in 3D company.

3D Printing
Series DOct 9, 2022
Amount Raised: $100,000,000